Megan A. Mullins

Dr. Megan A. Mullins

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
JGJoel J. Gagnier
Joel J. Gagnier
MMMegan A. Mullins
Megan A. Mullins
HHHsiaomin Huang
Hsiaomin Huang
DMDanica Marinac-Dabic
Danica Marinac-Dabic
AGAnna Ghambaryan
Anna Ghambaryan
MBManuel Bayona
Manuel Bayona

20 October 2021 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
MMMegan A. Mullins
Megan A. Mullins
JBJulie P. W. Bynum
Julie P. W. Bynum
SJSuzanne E. Judd
Suzanne E. Judd
PCPhilippa J. Clarke
Philippa J. Clarke
Background: Despite a growing burden of Alzheimer’s Disease and related dementias (ADRD) in the US, the relationship between health care and cognitive impairment prevention is unclear. Primary care manages risk causing conditions and risk reducing behaviors for dementia, so we examine the association between individual and area-level access to primary care and cognitive impairment in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Methods: REGARDS participants with a cognitive assessment and vascular measurements at their baseline visit were included in this cross-sectional analysis. Cognitive impairment was defined as a Six-Item Screener (SIS) score < 5. Primary care supply, primary care utilization and emergency department (ED) utilization were measured at the primary care service area (PCSA) level based on participant’s address. Individual access to care was self-reported. Models were adjusted for confounding by demographics, socioeconomic status and behavioral risk factors. Results: Among 25,563 adults, living in a PCSA with low primary care supply was associated with 25% higher odds of cognitive impairment (OR 1.25 CI 1.07-1.45). Not having a regular source of medical care was associated with 14% higher odds of cognitive impairment (OR 1.14 CI 1.02-1.28), and living in a PCSA with high emergency department utilization was associated with 12% higher odds of cognitive impairment (OR 1.12 CI 1.02-1.23). Conclusions: Our results are an important first step in understanding how health care may prevent cognitive impairment. They highlight the importance of primary care and suggest future work clarifying its role in preventing cognitive decline is imperative.

4 November 2021 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
MMMegan A. Mullins
Megan A. Mullins
JKJasdeep S. Kler
Jasdeep S. Kler
MEMarisa R. Eastman
Marisa R. Eastman
MKMohammed Kabeto
Mohammed Kabeto
LWLauren P. Wallner
Lauren P. Wallner
LKLindsay Kobayashi
Lindsay Kobayashi
Background: The US Health Retirement Study (HRS) is an ongoing population-representative cohort of US adults ages >50 with rich data on health during aging. Self-reported cancer diagnoses have been collected since 1998, but they have not been validated. We compared self-reported cancer diagnoses in HRS interviews against diagnostic claims from linked Medicare records. Methods: Using HRS–Medicare linked data, we examined the validity of first incident cancer diagnoses self-reported in biennial interviews from 2000 to 2016 against ICD-9 and ICD-10 diagnostic claim records as the gold standard. Data were from 8,242 HRS participants ages ≥65 with 90% continuous enrollment in fee-for-service Medicare. We calculated the sensitivity, specificity, and κ for first incident invasive cancer diagnoses (all cancers combined, and each of bladder, breast, colorectal/anal, uterine, kidney, lung, and prostate cancers) cumulatively over the follow-up and at each biennial study interview. Results: Overall, self-reports of first incident cancer diagnoses from 2000 to 2016 had 73.2% sensitivity and 96.2% specificity against Medicare claims (κ = 0.73). For specific cancer types, sensitivities ranged from 44.7% (kidney) to 75.0% (breast), and specificities ranged from 99.2% (prostate) and 99.9% (bladder, uterine, and kidney). Results were similar in sensitivity analyses restricted to individuals with 100% continuous fee-for-service Medicare enrollment and when restricted to individuals with at least 24 months of Medicare enrollment. Conclusions: Self-reported cancer diagnoses in the HRS have reasonable validity for use in population-based research that is maximized with linkage to Medicare. Impact: These findings inform the use of the HRS for population-based cancer and aging research.

9 January 2018 in JBJS Reviews
Verified
Journal Article
Closed access
PDF file
JGJoel Gagnier
Joel Gagnier
HHHsiaomin Huang
Hsiaomin Huang
MMMegan A. Mullins
Megan A. Mullins
DMDanica Marinac-Dabić
Danica Marinac-Dabić
AGAnna Ghambaryan
Anna Ghambaryan
MBManuel Bayona
Manuel Bayona
Background: Many patient-reported outcome measures (PROMs) have been developed to evaluate patient conditions before and after total hip arthroplasty. Also, many studies have been conducted to evaluate and compare the qualities of these instruments. Previously published reports suggest that most of these studies have poor methodology. Recently, 2 sets of criteria were developed for guiding and assessing the methodological and psychometric quality of these PROMs. We reviewed PROMs for total hip arthroplasty patients and appraised the methodological quality and psychometric evidence of evaluations of each identified instrument. Methods: Databases including PubMed, MEDLINE, Embase, CINAHL, the Cochrane Library, and others were searched for English-language articles published on or before April 14, 2017, using search terms related to outcome instrument, the condition or procedure of interest (hip arthroplasty), and psychometric properties. The methodological quality of the studies and the evidence of the psychometric properties were summarized and appraised using the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) checklist and the psychometric evidence criteria. Overall psychometric ratings were derived by combining the 2 criteria. Results: Seventy-three studies investigating 26 instruments were included. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford Hip Score, Harris hip score, and the Hip disability and Osteoarthritis Outcome Score (HOOS) were the most frequently assessed instruments. The WOMAC had 5 properties with positive evidence and was the highest-quality instrument overall, followed by the HOOS and the European Health Interview Survey (EUROHIS)-Quality of Life 8-item index. Conclusions: Despite a large number of included studies, many had low COSMIN ratings. We recommend additional rigorous studies to explore the psychometric properties of these instruments. Furthermore, the development of a core outcome set for total hip arthroplasty clinical trials is needed.

15 August 2019 in Cancer
Verified
Journal Article
Open access
PDF file
MMMegan A. Mullins
Megan A. Mullins
LPLauren C. Peres
Lauren C. Peres
AAAnthony J. Alberg
Anthony J. Alberg
EBElisa V. Bandera
Elisa V. Bandera
JIll S Barnholt-SloanJIll S Barnholt-Sloan
JIll S Barnholt-Sloan
MCMichele L. Cote
Michele L. Cote
Background: Discrimination and trust are known barriers to accessing health care. Despite well‐documented racial disparities in the ovarian cancer care continuum, the role of these barriers has not been examined. This study evaluated the association of everyday discrimination and trust in physicians with a prolonged interval between symptom onset and ovarian cancer diagnosis (hereafter referred to as prolonged symptom duration).Methods: Subjects included cases enrolled in the African American Cancer Epidemiology Study, a multisite case‐control study of epithelial ovarian cancer among black women. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of everyday discrimination and trust in physicians with a prolonged symptom duration (1 or more symptoms lasting longer than the median symptom‐specific duration), and it controlled for access‐to‐care covariates and potential confounders.Results: Among the 486 cases in this analysis, 302 women had prolonged symptom duration. In the fully adjusted model, a 1‐unit increase in the frequency of everyday discrimination increased the odds of prolonged symptom duration 74% (OR, 1.74; 95% CI, 1.22‐2.49), but trust in physicians was not associated with prolonged symptom duration (OR, 0.86; 95% CI, 0.66‐1.11).Conclusions: Perceived everyday discrimination was associated with prolonged symptom duration, whereas more commonly evaluated determinants of access to care and trust in physicians were not. These results suggest that more research on the effects of interpersonal barriers affecting ovarian cancer care is warranted.

19 May 2017 in Blood Advances
Verified
Journal Article
Open access
PDF file
MMMegan A. Mullins
Megan A. Mullins
XJXiaohui Jiang
Xiaohui Jiang
LBLauren C. Bylsma
Lauren C. Bylsma
JFJon P. Fryzek
Jon P. Fryzek
HRHeidi Reichert
Heidi Reichert
ARAdam Rosenthal
Adam Rosenthal
Key Points: This study demonstrates the severity of anemia and relapsing nature of CAD over time, even after administration of multiple therapies. The majority of CAD patients will at some point in their disease course manifest severe disease necessitating transfusion.